Biochemistry, Genetics and Molecular Biology
KRAS
100%
Kinase
65%
Phosphotransferase
65%
Small Molecule
38%
Guanosine Triphosphate
28%
Transcription
28%
Conformation
26%
RNA Polymerase II
25%
Crystal Structure
24%
Guanine
24%
Cancer Cell
23%
Adenosine Triphosphate
22%
Cysteine
20%
Mitogen-Activated Protein Kinase
18%
Competitive Inhibition
17%
Signal Transduction
17%
Binding Site
16%
Doublecortin
16%
Dynamics
15%
MEK Inhibitor
14%
Nucleotide Binding Site
13%
Dimerization
13%
T Cell
13%
EC50
13%
Nucleoside Triphosphate
12%
Mechanistic Target of Rapamycin
12%
Kinome
11%
RNA
10%
Promoter Region
10%
DNA Repair
10%
Covalent Bond
10%
Hope
10%
Enzymatic Hydrolysis
10%
Active Site
9%
Mass Spectrometry
9%
Protein Kinases
9%
Binding Kinetics
9%
Drug Resistance
9%
GTPase
9%
Gene Expression
9%
N-Terminus
8%
Wild Type
8%
Codon
8%
Isoform
7%
RNA Processing
7%
Small GTPase
7%
Western Blot
7%
Catenin
7%
CDC37
7%
Cell Proliferation
7%
Medicine and Dentistry
Radiation Therapy
83%
Non Small Cell Lung Cancer
72%
Neoplasm
46%
Stereotactic Body Radiation Therapy
41%
Metastatic Carcinoma
24%
Malignant Neoplasm
19%
Phosphotransferase
18%
Lung Cancer
18%
Randomized Clinical Trial
15%
Cervical Cancer
15%
Radiomics
15%
Disease
14%
Overall Survival
11%
Heterotopic Ossification
11%
Kinase
11%
Cancer Therapy
10%
Adenosine Triphosphate
10%
Drug Therapy
10%
Combination Therapy
10%
Intensity Modulated Radiation Therapy
8%
Nonsteroid Antiinflammatory Agent
8%
Prognostic Factor
8%
Hypofractionated Radiotherapy
8%
Local Therapy
8%
Chemoradiotherapy
7%
Tissue Regeneration
7%
Phase II Trials
7%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
7%
Autoimmune Disease
7%
Tumor Necrosis Factor
7%
Adaptive Radiation
7%
Signaling Protein
7%
Neutrophil
7%
Ossification
7%
Stereotactic Radiation Therapy
7%
Human Immunodeficiency Virus
7%
Androgen
7%
Tumor Recurrence
7%
Mesenchymal-Epithelial Transition
7%
Lapatinib
7%
Contact Examination
7%
Cysteine
7%
Cyclooxygenase 2
7%
Prostatectomy
7%
Prostate Cancer
7%
Pancreas Cancer
7%
Tumor Mutation Burden
7%
Neck
7%
COVID-19
7%
Uvomorulin
7%
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
33%
Stereotactic Ablative Radiotherapy
28%
KRAS G12C
16%
KRAS mutation
16%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
15%
Torin2
15%
Pyrimido
15%
Diazepin
15%
Doublecortin-like Kinase 1 (DCLK1)
15%
Metastatic Non-small Cell Lung Cancer
15%
G12C
15%
Randomized Clinical Trial
15%
KRAS mutant
15%
Tumor
13%
KRAS Variant
11%
Adaptive Radiotherapy
10%
Hypofractionation
10%
Switch Region
10%
Dynamic Equilibrium
10%
Poor Performance Status
10%
Tumor Growth
9%
Early-stage Lung Cancer
8%
Radiotherapy
8%
Radiation Therapy
8%
Radiation-induced DNA Damage
8%
Local Therapy
8%
ATP-competitive
8%
DNA Damage
8%
Type II Inhibitor
7%
MAP4K2
7%
Response to Immunotherapy
7%
Genome-wide Distribution
7%
TAK1 Inhibitor
7%
Differential Sensitivity
7%
Cyclooxygenase-1/2
7%
KRAS Dimerization
7%
Client Engagement
7%
Cervical Cancer Metastasis
7%
Direct Targeting
7%
On Demand
7%
Treatment Regimen
7%
Radiomics Model
7%
Proteasomal Degradation
7%
Cocrystal
7%
Macrophage Function
7%
Polypharmacology
7%
Tailored Therapy
7%
Dose-escalation Trial
7%
NRAS-mutant Melanoma
7%
α-mangostin
7%
